Up-regulation of NMRK2 mediated by TFE3 fusions is the key for energy metabolism adaption of Xp11.2 translocation renal cell carcinoma
- 18 April 2022
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 538, 215689
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Restricted leucine zipper dimerization and specificity of DNA recognition of the melanocyte master regulator MITFGenes & Development, 2012
- The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome HomeostasisScience Signaling, 2012
- A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEBThe EMBO Journal, 2012
- Grade-dependent Proteomics Characterization of Kidney CancerMolecular & Cellular Proteomics, 2009
- NAD + /NADH and NADP + /NADPH in Cellular Functions and Cell Death: Regulation and Biological ConsequencesAntioxidants & Redox Signaling, 2008
- Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivationviaarginine deiminaseInternational Journal of Cancer, 2006
- Melanocytes and theMicrophthalmiaTranscription Factor NetworkAnnual Review of Genetics, 2004
- The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor geneHuman Molecular Genetics, 1996
- Fine mapping of the 1q21 breakpoint of the papillary renal cell carcinoma-associated (X;1) translocationHuman Genetics, 1996
- Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2)and the first report of a female caseCytogenetic and Genome Research, 1995